In analyzing determinants of event occurrence the authors identified a role for CV risk factors, in particular hypertension and history of atrial fibrillation or heart failure; interestingly, however, there was no information on clinical usage of anti-IL6 medications to mitigate CRS in these patients [25]. The gene discussed is IL6; the disease is congenital rubella syndrome.